Bespoke Extracts, Inc.
CIK 1409197fmd_1SRE6K13THPYESN89Y7GB716GKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2010 to Sep 30, 2025, 64 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | 0 | – | – | 0 | 1 | 1 |
| Cost of revenue | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Gross profit | – | – | – | (0) | (0) | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 0 | 0 | 6 | 7 | (4) | – | – | 4 | 2 | 1 |
| Total operating expenses | 1 | 0 | 7 | 7 | (3) | 4 | 1 | 4 | 2 | 1 |
| Operating income | (1) | (0) | (7) | (7) | 3 | (4) | (1) | (4) | (1) | (1) |
| Interest expense | – | 0 | 0 | 0 | 0 | 1 | – | – | 0 | 0 |
| Interest and investment income | – | – | – | – | – | – | – | 0 | – | – |
| Other non-operating income (expense) | – | (0) | (0) | (0) | (0) | (1) | – | (0) | (0) | (0) |
| Income before taxes | (1) | (0) | (7) | (8) | 3 | (5) | (1) | (4) | (1) | (1) |
| Net income | (1) | (0) | (7) | (8) | 3 | (5) | (1) | (4) | (1) | (1) |
| Net income to common shareholders | – | – | – | – | – | – | – | 1 | 0 | 0 |